4//SEC Filing
Susan Lior 4
Accession 0001209191-21-009046
CIK 0001652724other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:55 PM ET
Size
25.0 KB
Accession
0001209191-21-009046
Insider Transaction Report
Form 4
Susan Lior
Director10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+877,445→ 1,854,297 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09$13.60/sh+473,729$6,442,714→ 4,183,986 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09+185,512→ 2,039,809 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09+976,852→ 976,852 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-02-09−976,852→ 0 total(indirect: See footnote)→ Common Stock (976,852 underlying) - Conversion
Series C Preferred Stock
2021-02-09−185,512→ 0 total(indirect: See footnote)→ Common Stock (185,512 underlying) - Conversion
Series C Preferred Stock
2021-02-09−3,710,257→ 0 total(indirect: See footnote)→ Common Stock (3,710,257 underlying) - Conversion
Common Stock
2021-02-09+3,710,257→ 3,710,257 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-02-09−877,445→ 0 total(indirect: See footnote)→ Common Stock (877,445 underlying) - Conversion
Convertible Promissory Note
2021-02-09→ 0 total(indirect: See footnote)Exercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)
Footnotes (4)
- [F1]Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.
- [F2]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
- [F3]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
- [F4]The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO.
Documents
Issuer
Lucira Health, Inc.
CIK 0001652724
Entity typeother
Related Parties
1- filerCIK 0001832895
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 7:55 PM ET
- Size
- 25.0 KB